Circuit Clinical Collaborates with CUBRC

By CIOReview | Thursday, May 16, 2019

FREMONT, CA: Circuit Clinical, one of the world's leading integrated research organizations in the U.S. dedicated to providing patients with traditional treatment substitutes from 2015, announced a strategic partnership with CUBRC. Founded in 1983, CUBRC specializes in independent non-profit research and development on advanced statistical science, information fusion, biomedical, and biochemical market. The union has lead to the merging of Circuit Clinical's exclusive patient-physician network, TrialScout's state-of-the-art clinical trial guiding platform, and CUBRC's expertise in data sciences by the deployment of specialized analytical tools. The agreement will enhance and unlock the limitless possibilities in healthcare services by providing a mesh of undisclosed genetic data used for disease detection and body analysis.

Dr. Irfan Khan, CEO of Circuit Clinical is positive that with the efficient utilization of life science data achieved from the agreement will not only guide the discovery of new medicines and antibiotics but also decrease the clinical trial-time and execution errors. The TrialScout platform will calculate donors' and patient's genomic and healthcare data, enabling proper treatment and body-analysis by the physicians and doctors. Circuit Clinical will also offer data owners the remote access to their datasets for data-privacy and data-security. New partnership with University at Buffalo Biorepository will permit Circuit Clinical the ability to sequence and reserve donated biosamples. CUBRC's Health Insurance Portability and Accountability Act (HIPAA) platform and data science expertise will provide a detailed computation analysis and will further help to drive the discovery of unique and new pharmaceutics. The collaboration will allow Circuit Clinical to utilize CUBRC's artificial intelligence (AI) and machine learning (ML) platforms in providing high-confidence predictions of overall productivity and individual patient response to next-generation therapies.

With the strategic partnership, Circuit Clinical will have the authority of CUBRC's Heartwood Analytics ML platform for statistical analysis by data assay and new insights on drug discovery. The collaboration will permit Circuit Clinical and CUBRC to partner with National Institutes of Health (NIH) and Department of Defense (DoD) data science and healthcare projects.